DNA hypermethylation of MAL gene may act as an independent predictor of favorable prognosis in patients with colorectal cancer

BACKGROUND: Aberrant DNA methylation could be used as biomarkers for colorectal cancer (CRC) detection and assessment of prognosis. The aim of our study was to investigate the potential possibility of MAL methylation as a prognostic biomarker for postoperative CRC patients. METHODS: We followed up 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xinyan, Bi, Haoran, Ge, Anqi, Xia, Tingting, Fu, Jinming, Liu, Yupeng, Sun, Hongru, Li, Dapeng, Zhao, Yashuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799055/
https://www.ncbi.nlm.nih.gov/pubmed/35116947
http://dx.doi.org/10.21037/tcr.2019.09.04

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799055/
https://www.ncbi.nlm.nih.gov/pubmed/35116947
http://dx.doi.org/10.21037/tcr.2019.09.04

Ejemplares similares